Risk ofPneumocystis jiroveciipneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis: Table 1

Factor Α ◽

Necrosis Factor ◽

Factors predicting pain and early discontinuation of tumour necrosis factor-α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register

BMC Musculoskeletal Disorders ◽

10.1186/s12891-016-1192-7 ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 19

Author(s):

Daniel F. McWilliams ◽

David A. Walsh

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

British Society ◽

Early Discontinuation ◽

Factor Α ◽

Necrosis Factor ◽

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/s0093-3619(09)79495-x ◽

2010 ◽

Vol 2010 ◽

pp. 137-138

Author(s):

M. Lebwohl

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

British Society ◽

Factor Α ◽

Necrosis Factor ◽

Biologics Register ◽

New Onset

SAT0355 Risk and Characteristics of Drug Induced Vasculitis in Patients Exposed to Tumour Necrosis Factor α Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

10.1136/annrheumdis-2015-eular.1726 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 787.3-788

Author(s):

M. Jani ◽

W. Dixon ◽

L. Kearsley-Fleet ◽

I. Bruce ◽

H. Chinoy ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

British Society ◽

Drug Induced ◽

Factor Α ◽

Necrosis Factor ◽

SAT0148 Does depression affect response to anti-tumour necrosis factor-α therapy in patients with rheumatoid arthritis (RA)? Results from the british society for rheumatology biologics register (BSRBR):

10.1136/annrheumdis-2012-eular.3095 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 521.3-522

Author(s):

R. Davies ◽

L.K. Mercer ◽

J.B. Galloway ◽

A.S. Low ◽

K.D. Watson ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

British Society ◽

Factor Α ◽

Necrosis Factor ◽

O10. Risk and Characteristics of Drug-Induced Lupus in Patients Exposed to Tumour Necrosis Factor-α Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology ◽

10.1093/rheumatology/kev080.004 ◽

2015 ◽

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

British Society ◽

Drug Induced ◽

Factor Α ◽

Necrosis Factor ◽

FRI0358 Risk and Characteristics of Drug Induced Lupus in Patients Exposed to Tumour Necrosis Factor-α Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

10.1136/annrheumdis-2015-eular.1548 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 555.2-556

Author(s):

M. Jani ◽

L. Kearsley-Fleet ◽

W. Dixon ◽

I. Bruce ◽

H. Chinoy ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Inhibitor Therapy ◽

British Society ◽

Drug Induced ◽

Factor Α ◽

Necrosis Factor ◽

Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs

Rheumatology International ◽

10.1007/s00296-009-1012-6 ◽

2009 ◽

Vol 30 (7) ◽

pp. 977-978 ◽

Cited By ~ 4

Author(s):

Erika Angelucci ◽

Monica Cesarini ◽

Piero Vernia

Keyword(s):

Rheumatoid Arthritis ◽

Myasthenia Gravis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Immunosuppressive Drugs ◽

Concomitant Treatment ◽

Successful Resolution ◽

Factor Α ◽

Necrosis Factor

FLOW CYTOMETRICAL DETERMINATION OF INTERLEUKIN 1β, INTERLEUKIN 6 AND TUMOUR NECROSIS FACTOR α IN MONOCYTES OF RHEUMATOID ARTHRITIS PATIENTS; RELATION WITH PARAMETERS OF OSTEOPOROSIS

Cytokine ◽

10.1006/cyto.1998.0500 ◽

1999 ◽

Vol 11 (11) ◽

pp. 869-874 ◽

Cited By ~ 12

Author(s):

Ann Verbruggen ◽

Luc S De Clerck ◽

Chris H Bridts ◽

Jan F Van Offel ◽

Wim J Stevens

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Interleukin 1Β ◽

Factor Α ◽

Necrosis Factor

Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritis

10.1136/annrheumdis-2015-208001 ◽

2015 ◽

Vol 75 (10) ◽

pp. 1757-1762 ◽

Cited By ~ 19

Author(s):

Theresa Wampler Muskardin ◽

Priyanka Vashisht ◽

Jessica M Dorschner ◽

Mark A Jensen ◽

Beverly S Chrabot ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Factor Α ◽

Pretreatment Serum ◽

Necrosis Factor

086 A longitudinal analysis of prevalence of sustained remission and low disease activity in rheumatoid arthritis patients treated with anti-tumour necrosis factor: an analysis of the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology ◽

10.1093/rheumatology/key075.310 ◽

2018 ◽

Vol 57 (suppl_3) ◽

Author(s):

Philip D H Hamann ◽

Gavin Shaddick ◽

Neil McHugh ◽

Kimme Hyrich ◽

John D Pauling

Keyword(s):

Rheumatoid Arthritis ◽

Disease Activity ◽

Tumour Necrosis Factor ◽

Longitudinal Analysis ◽

Tumour Necrosis ◽

British Society ◽

Sustained Remission ◽

Low Disease Activity ◽

Necrosis Factor ◽